|
|
|
| home > white papers > Biosimilars In Emerging Markets: Is It A Level Playing Field? - PRA Health Sciences (PRA) |
|
|
 WHITE PAPERS |
|
PRA Health Sciences (PRA)
|
|
Biosimilars In Emerging Markets: Is It A Level Playing Field?
|
|
Governments, healthcare payers, and social and health reforms, combined
with the increased incidence of conditions such as cancer and diabetes
are paving the way for increased uptake of biologic medicines in
emerging markets. However, expensive biologic medicines can be
prohibitive to many patients, creating a high level of unmet clinical
need. At its best, the global expansion of biosimilars can mean a robust
and steady supply of existing and new drugs reaching far-flung patient
populations, but localized biosimilar drug developments, especially in
China and India, combined with a lack of robust pharmacovigilance
systems, threaten to derail the industry by putting patient health at
risk.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
BioIVT Appoints Alan Findlater as Chief Commercial Officer
BioIVT, a leading provider of research models and services for drug and
diagnostic development, today announced that it has appointed Alan
Findlater to the newly-created role of chief commercial officer. In his
new position, Mr. Findlater will be responsible for all of BioIVT’s
commercial activities, including global sales, marketing and customer
service.
More info >> |
|
 |
White Papers |
 |
|
Advanced BioDesign Outlines Solutions
Advanced BioDesign
Launching an immunisation programme is an important experimental step that needs care. With Advanced BioDesign, clients may develop and produce antibodies according to customers' specific needs. The company offers: real support and advice from a dedicated team all along your project; large and modern SPF animal facility; ethical treatment of animals. The evaluation of a project is free-of-charge and with no obligation. Dedicated project managers will work with clients from the beginning to the end of a custom antibody project to ensure the highest level of quality and service.
More info >> |
|
 |
Industry Events |
 |
Biotech Showcase™ 2019
7-9 January 2019, Hilton San Francisco Union Square
Biotech
Showcase™ is an investor and networking conference devoted to
providing private and small- and mid-cap biotechnology companies an opportunity
to present to and meet with investors and biopharmaceutical executives during
the course of one of the largest annual healthcare conferences that attracts
investors and biopharmaceutical executives from around the world.
More info >> |
|
|
|
